Awakn Announces Voluntary Lock-Up Agreement Extension With Management, Board Of Directors And Key Shareholders
Management, the Board of Directors, and key shareholders represent approximately 11.5 million shares or 46.1% of the issued and outstanding shares. TORONTO, CANADA, 04 January 2022 – Awakn Life Sciences Corp….